Safety profiles were generally similar for ataluren and placebo , except for the occurrence of increased creatinine concentrations ( ie , acute kidney injury ) , which occurred in @ ( @ % ) of @ patients in the ataluren group compared with one ( < @ % ) of @ patients in the placebo group .